Abingworth

Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:

Companies in the Abingworth portfolio as of June 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Crispr Therapeutics Ag 31.01 -6% 2.44M 15.94
Paratek Pharmaceuticals 24.89 1.30M 24.05
Sientra 16.97 2.20M 9.70
Cymabay Therapeutics 7.33 1.60M 5.76
Cascadian Therapeutics 2.73 925000 3.71
Immune Design 2.71 352300 9.65
Proteon Therapeutics 2.41 2.02M 1.50
Chiasma 2.32 2.08M 1.40
Cellectis S A sponsored ads 2.04 100000 25.66
Dermira 1.62 70000 29.11
Lombard Med 1.44 3.47M 0.52
Histogenics Corp Cmn 1.26 888889 1.78
Aurinia Pharmaceuticals 1.23 252129 6.12
Innocoll Ag 0.97 537235 2.27
Adaptimmune Therapeutics 0.90 250000 4.50
Novan 0.17 53367 4.03

Past 13F-HR SEC Filings by Abingworth

View All Filings